CSL: Half Yearly Report and Accounts
Filed with ASX ·
Watch CSL's latest callCSL (ASX:CSL) Q4 2026 Earnings Call · Replay · Aug 18Read the transcript of CSL (ASX:CSL) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Story so far
Earlier from CSL
- Appendix 4E, FY Results and Analysts Presentation
- Changes relating to buy-back - Appendix 3D
- IDELVION(R) (rFIX-FP) - FDA approval
- IDELVION(R) (rFIX-FP) - CHMP recommendation
- Half Year Accounts
Later from CSL
- CSL Settles US Class Action and Updated Profit Guidance
- Full Year Results, Appendix 4E and Analysts Presentation
- New US$500 million Private Placement
- Appointment of Paul Perreault as Executive Director
- Announcement of buy-back
Follow CSL into a list and get an email when it puts out news.
Follow CSL